Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian H Kushner

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
Neuroblastoma: a disease requiring a multitude of imaging studiesBrian H Kushner
International Journal of Radiation Oncology, Biology, Physics|August 6, 2018
Short Hypofractionated Radiation Therapy in Palliation of Pediatric Malignancies: Outcomes and ToxicitiesStanislav Lazarev, Brian H Kushner, Suzanne L Wolden
Cancer|September 7, 2002
Chronic neuroblastomaBrian H Kushner, Kim Kramer, Nai-Kong V Cheung
Journal of Pediatric Hematology/Oncology|August 7, 2003
Oral topotecan for refractory and relapsed neuroblastoma: a retrospective analysisKim Kramer, Brian H Kushner, Nai-Kong V Cheung
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Irinotecan plus temozolomide for relapsed or refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I studyBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Cancer|January 8, 2005
Five-day courses of irinotecan as palliative therapy for patients with neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Blood & Cancer|November 5, 2010
High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecanBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
Neuroblastoma: a disease requiring a multitude of imaging studiesBrian H Kushner
International Journal of Radiation Oncology, Biology, Physics|August 6, 2018
Short Hypofractionated Radiation Therapy in Palliation of Pediatric Malignancies: Outcomes and ToxicitiesStanislav Lazarev, Brian H Kushner, Suzanne L Wolden
Cancer|September 7, 2002
Chronic neuroblastomaBrian H Kushner, Kim Kramer, Nai-Kong V Cheung
Journal of Pediatric Hematology/Oncology|August 7, 2003
Oral topotecan for refractory and relapsed neuroblastoma: a retrospective analysisKim Kramer, Brian H Kushner, Nai-Kong V Cheung
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Irinotecan plus temozolomide for relapsed or refractory neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 28, 2009
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2011
Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I studyBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2004
Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Cancer|January 8, 2005
Five-day courses of irinotecan as palliative therapy for patients with neuroblastomaBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pediatric Blood & Cancer|November 5, 2010
High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecanBrian H Kushner, Kim Kramer, Shakeel Modak, et al.
Pageof 11